|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/13/21 AVROBIO, Inc. 10-Q 3/31/21 62:5.3M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 847K
2: EX-10.1 Amendment to Employment Agreement, by and Between HTML 22K
the Registrant and Geoff Mackay, Dated April 5,
2021.
3: EX-10.2 Amendment to Employment Agreement, by and Between HTML 22K
the Registrant and Erik Ostrowski, Dated April 5,
2021.
4: EX-10.3 Amendment to Employment Agreement, by and Between HTML 22K
the Registrant and Steven Avruch, Dated April 5,
2021.
5: EX-10.4 Amendment to Employment Agreement, by and Between HTML 22K
the Registrant and Diana Escolar, Md, Dated April
5, 2021.
6: EX-10.5 Amendment to Employment Agreement, by and Between HTML 22K
the Registrant and Chris Mason, Dated April 5,
2021.
7: EX-10.6 Amendment to Employment Agreement, by and Between HTML 22K
the Registrant and Deanna Petersen, Dated April 5,
2021.
8: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
9: EX-31.2 Certification -- §302 - SOA'02 HTML 28K
10: EX-32.1 Certification -- §906 - SOA'02 HTML 23K
17: R1 Document and Entity Information HTML 78K
18: R2 Condensed Consolidated Balance Sheets HTML 85K
19: R3 Condensed Consolidated Balance Sheets HTML 37K
(Parenthetical)
20: R4 Condensed Consolidated Statements of Operations HTML 54K
and Comprehensive Loss
21: R5 Condensed Consolidated Statements of Stockholders' HTML 54K
Equity
22: R6 Condensed Consolidated Statements of Stockholders' HTML 22K
Equity (Parenthetical)
23: R7 Condensed Consolidated Statements of Cash Flows HTML 86K
24: R8 Nature of the Business HTML 25K
25: R9 Summary of Significant Accounting Policies HTML 43K
26: R10 License Agreements HTML 41K
27: R11 Fair Value Measurement HTML 78K
28: R12 Supplemental Balance Sheet Information HTML 99K
29: R13 Commitments and Contingencies HTML 25K
30: R14 Stockholders' Equity HTML 52K
31: R15 Stock-Based Compensation HTML 126K
32: R16 Net Loss Per Share HTML 34K
33: R17 Related Party Transactions HTML 24K
34: R18 Summary of Significant Accounting Policies HTML 58K
(Policies)
35: R19 Fair Value Measurement (Tables) HTML 77K
36: R20 Supplemental Balance Sheet Information (Tables) HTML 105K
37: R21 Stockholders' Equity (Tables) HTML 54K
38: R22 Stock-Based Compensation (Tables) HTML 131K
39: R23 Net Loss Per Share (Tables) HTML 33K
40: R24 Nature of the Business - Additional Information HTML 34K
(Detail)
41: R25 Summary of Significant Accounting Policies - HTML 22K
Additional Information (Detail)
42: R26 License Agreements - Additional Information HTML 88K
(Detail)
43: R27 Fair Value Measurement - Summary of Financial HTML 29K
Assets Measured at Fair Value on Recurring Basis
(Detail)
44: R28 Fair Value Measurement - Additional Information HTML 21K
(Detail)
45: R29 Supplemental Balance Sheet Information - Summary HTML 32K
of Prepaid Expenses and Other Current Assets
(Detail)
46: R30 Supplemental Balance Sheet Information - Summary HTML 34K
of Property and Equipment, Net (Detail)
47: R31 Supplemental Balance Sheet Information - HTML 22K
Additional Information (Detail)
48: R32 Supplemental Balance Sheet Information - Summary HTML 22K
of Restricted Cash (Detail)
49: R33 Supplemental Balance Sheet Information - Summary HTML 31K
of Accrued Expenses (Detail)
50: R34 Stockholders' Equity - Additional Information HTML 29K
(Detail)
51: R35 Stockholders' Equity - Summary of Common Stock HTML 35K
Reserved for Future Issuance (Detail)
52: R36 Stock-Based Compensation - Summary of Assumptions HTML 28K
that Used to Determine Grant-Date Fair Value of
Stock Options Granted to Employees and Members of
Board of Directors (Detail)
53: R37 Stock-Based Compensation - Summary of Stock Option HTML 54K
Activity (Detail)
54: R38 Stock-Based Compensation - Additional Information HTML 32K
(Detail)
55: R39 Stock-Based Compensation - Summary of Restricted HTML 32K
Common Stock Units (Detail)
56: R40 Stock-Based Compensation - Schedule of Stock-based HTML 27K
Compensation Expense (Detail)
57: R41 Net Loss Per Share - Schedule of Dilutive Common HTML 27K
Stock Equivalents Excluded from Computation of
Diluted Net Loss per Share (Detail)
58: R42 Related Party Transactions - Additional HTML 30K
information (Detail)
60: XML IDEA XML File -- Filing Summary XML 102K
16: XML XBRL Instance -- avro-10q_20210331_htm XML 1.02M
59: EXCEL IDEA Workbook of Financial Reports XLSX 59K
12: EX-101.CAL XBRL Calculations -- avro-20210331_cal XML 90K
13: EX-101.DEF XBRL Definitions -- avro-20210331_def XML 189K
14: EX-101.LAB XBRL Labels -- avro-20210331_lab XML 714K
15: EX-101.PRE XBRL Presentations -- avro-20210331_pre XML 484K
11: EX-101.SCH XBRL Schema -- avro-20210331 XSD 112K
61: JSON XBRL Instance as JSON Data -- MetaLinks 207± 326K
62: ZIP XBRL Zipped Folder -- 0001564590-21-027619-xbrl Zip 206K
Exhibit 10.1
AMENDMENT TO EMPLOYMENT AGREEMENT
WHEREAS, AVROBIO, Inc. and Geoff MacKay (the “Executive”) (collectively the “Parties”) entered into the Employment Agreement dated June 8, 2018 (the “Employment Agreement”); and
WHEREAS, the Parties have agreed to modify the Employment Agreement.
NOW, THEREFORE, pursuant to Section 17 of the Employment Agreement, the Parties hereby amend the Employment Agreement as follows:
1.Section 2(e) of the Employment Agreement is deleted in its entirety and replaced by the following provision:
During the Term, the Executive shall be entitled to a paid vacation in accordance with the Company’s policies and procedures which, for the Company’s Executive Team Members (including the Executive), is a flexible, nonaccrual policy which became effective on January 1, 2020. The Executive shall also be entitled to all paid holidays given by the Company to its executive officers.
2.All other provisions of the Employment Agreement shall remain in full force and effect.
IN WITNESS WHEREOF, the Parties hereby have executed this Amendment on April 5, 2021.
AVROBIO, INC.
/s/ Bruce Booth_________________________
By: Bruce Booth
Its: Chairman of the Board of Directors
EXECUTIVE
/s/ Geoff MacKay_______________________
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/13/21 | 8-K | ||
| 4/5/21 | ||||
| For Period end: | 3/31/21 | |||
| 1/1/20 | ||||
| 6/8/18 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/15/24 AVROBIO, Inc. S-4/A 91:17M Donnelley … Solutions/FA 3/26/24 AVROBIO, Inc. S-4/A 3/25/24 89:18M Donnelley … Solutions/FA 3/14/24 AVROBIO, Inc. 10-K 12/31/23 80:9.4M Donnelley … Solutions/FA 2/14/24 AVROBIO, Inc. S-4 91:25M Donnelley … Solutions/FA 3/23/23 AVROBIO, Inc. 10-K 12/31/22 82:10M Donnelley … Solutions/FA 3/17/22 AVROBIO, Inc. 10-K 12/31/21 78:9.1M ActiveDisclosure/FA 8/05/21 AVROBIO, Inc. 10-Q 6/30/21 55:5.8M ActiveDisclosure/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/05/20 AVROBIO, Inc. 10-Q 9/30/20 61:6.1M ActiveDisclosure/FA 6/25/18 AVROBIO, Inc. 8-K:5,9 6/20/18 3:148K Donnelley … Solutions/FA |